Skip to content

A clinical trial to determine if AIC263029 is safe when dosed only once or several times, and to investigate how it moves within the human body

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510074-13-00
Acronym
AIC468-01-I-01
Enrollment
104
Registered
2024-03-15
Start date
2024-10-02
Completion date
Unknown
Last updated
2025-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BKV-associated nephropathy

Interventions

None listed

Sponsors

AiCuris Anti-infective Cures AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026